Thrombosis Management and Challenges in COVID-19 Patients Presenting with Acute Coronary Syndromes

Rasha Kaddoura; Amar M Salam

doi:10.4103/HEARTVIEWS.HEARTVIEWS_143_20

Thrombosis Management and Challenges in COVID-19 Patients Presenting with Acute Coronary Syndromes

Heart Views. 2020 Jul-Sep;21(3):195-208. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_143_20. Epub 2020 Oct 13.

Authors

Rasha Kaddoura¹, Amar M Salam^{2

3}

Affiliations

¹ Department of Cardiology and Cardiovascular Surgery,Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
² Department of Cardiology, Al Khor Hospital, Hamad Medical Corporation, Doha, Qatar.
³ College of Medicine, QU Health, Qatar University, Doha, Qatar.

PMID: 33688412
PMCID: PMC7898995
DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_143_20

Abstract

Thrombotic complications in patients with coronavirus disease 2019 (COVID-19) infection have been increasingly recognized, particularly those affecting the cardiovascular system. Patients with COVID-19 infection can suffer from increased coagulopathy as well as myocardial injury. In this review, we discuss these complications with special focus on management challenges in patients with acute coronary disease based on the available evidence from published literature.

Keywords: COVID-19; SARS-CoV-2; Scute coronary syndrome; coagulopathy; myocardial injury; percutaneous coronary intervention; severe acute respiratory syndrome-coronavirus-2; thromboembolic disease.

Publication types

Review